Skip to content
TrialScanner

NCT05397431

A Survey of Lanadelumab in Participants With Hereditary Angioedema

No phase registeredCompletedTAKLead

Registry record

Lead sponsor
Takeda
Conditions
Hereditary Angioedema (HAE)
Primary completion
Oct 27, 2026Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT05397431 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

3 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT05397431: A Survey of Lanadelumab in... | TrialScanner